Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
UK NCRI Haemato-oncology Clinical Studies Group, Graham H. Jackson*, Faith E. Davies, Charlotte Pawlyn, David A. Cairns, Alina Striha, Corinne Collett, Anna Hockaday, John R. Jones, Bhuvan Kishore, Mamta Garg, Cathy D. Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W. Jenner, Gordon Cook, Nigel H. Russell, Martin F. Kaiser, Mark T. Drayson, Roger G. OwenWalter M. Gregory, Gareth J. Morgan
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
106Citations
(Scopus)
185Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial'. Together they form a unique fingerprint.